Filings

4 documents · 20 matches

1. RKDA Arcadia Biosciences, Inc. 10-Q 2026-08-13

   Item 4. Controls and Procedures

   material weaknesses in our internal control over financial reporting as described below. Notwithstanding these material weaknesses, management concluded that our consolidated
   5 matches in this document Show context Copy citation

2. RKDA Arcadia Biosciences, Inc. 10-Q 2026-05-14

   Item 4. Controls and Procedures

   material weaknesses in our internal control over financial reporting as described below. Notwithstanding these material weaknesses, management concluded that our consolidated
   5 matches in this document Show context Copy citation

3. RKDA Arcadia Biosciences, Inc. 10-K 2026-03-26

   Item 9A. Controls and Procedures.

   material weaknesses are remediated. In this remediation process, which involve designing and implementing controls and processes to address the material
   8 matches in this document Show context Copy citation

4. RKDA Arcadia Biosciences, Inc. 8-K 2026-04-03

   Item 4.01. Changes in Registrant’s Certifying Accountant.

   material weaknesses in its internal control over financial reporting as of and for the year ended December 31, 2025, as disclosed
   2 matches in this document Show context Copy citation